Eton Pharmaceuticals Files 8-K
Ticker: ETON · Form: 8-K · Filed: Jul 8, 2025 · CIK: 1710340
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Eton Pharma filed an 8-K on 7/8/25 - check for updates.
AI Summary
Eton Pharmaceuticals, Inc. filed an 8-K on July 8, 2025, to report other events and financial statements. The filing does not contain specific details about the nature of these events or financial figures within the provided text.
Why It Matters
This filing indicates a regulatory update from Eton Pharmaceuticals, Inc., which could contain material information for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for other events and financial statements, with no immediate indication of significant risk in the provided text.
Key Players & Entities
- Eton Pharmaceuticals, Inc. (company) — Registrant
- July 08, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Deer Park, Illinois (location) — Principal Executive Offices
FAQ
What specific events are being reported in this 8-K filing?
The provided text states the filing is for 'Other Events' and 'Financial Statements and Exhibits' but does not detail the specific events.
When was this 8-K filing submitted?
The filing was submitted on July 08, 2025.
What is Eton Pharmaceuticals, Inc.'s principal executive office address?
The principal executive offices are located at 21925 W. Field Parkway, Suite 235, Deer Park, Illinois 60010-7278.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is Eton Pharmaceuticals, Inc.'s IRS Employer Identification Number?
The IRS Employer Identification Number for Eton Pharmaceuticals, Inc. is 37-1858472.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 8, 2025 regarding Eton Pharmaceuticals, Inc. (ETON).